Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RxSpan MD vs telos rx

RxSpan MD
Graded #10

Higher grade

vs+1
telos rx
Graded #15

Lower grade

The verdict

RxSpan MD takes it — 86/100 to 85/100, but only just.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A physician-led telehealth under board-certified founder Dr. John Diaz with a broad GLP-1 menu — compounded semaglutide and tirzepatide by injection or oral capsule, plus a brand-name lane and microdosing — on transparent all-inclusive pricing to all 50 states. telos rx is close behind and may still be the better fit — see the factor split below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuetelos rx +1
86
87
Dose & formulationtelos rx +1
89
90
Clinical oversightRxSpan MD +4
88
84
Labs & monitoringRxSpan MD +3
83
80
FulfillmentRxSpan MD +2
89
87
Contract termsRxSpan MD +5
85
80
RxSpan MD · left bartelos rx · right bar

The numbers

MetricRxSpan MDtelos rx
WeighScore86/10085/100
GradeBB
Scorecard rank#10#15
SemaglutideFrom $194/moFrom $49/mo (annual)
Tirzepatide$329/mo$99/mo (annual)
CoverageAll 50 statesNot publicly listed
Brand-name accessYesCompounded only
Oral / sublingualYesYes
RxSpan MD

Graded #10 · B

Strengths

  • Available in all 50 states
  • Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support, cancel anytime, from ~$194/mo compounded semaglutide on an annual plan
  • Both injectable and a real oral (capsule) route, plus compounded and an advertised brand-name lane
  • Physician-led by a named, board-certified founder (Dr. John Diaz) with 24/7 messaging and coaching

Where it loses points

  • Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
  • Published pricing is for the compounded line — brand-name pricing isn’t itemized
  • A prescription isn’t guaranteed — a provider reviews eligibility after checkout
telos rx

Graded #15 · B

Strengths

  • Deep published catalog — sema, tirz, PT-141, intranasal NAD+, recovery/GH peptides, GHK-Cu, Dihexa, HRT
  • Needle-free and oral GLP-1 options, not injection-only
  • LegitScript-certified and HIPAA, with US providers and pharmacies, HSA/FSA and free shipping
  • Low GLP-1 entry — from $49/mo microdosed on an annual plan

Where it loses points

  • Everything is compounded and not FDA-approved, including the peptides
  • Pricing is opaque outside GLP-1 and the lowest rates require annual lock-in
  • No named clinicians and thin third-party reviews
  • Several research-grade peptides carry limited clinical evidence

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 34 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard